|
Sex/age | Autoantibodies (anti-SSA/anti-SSB) | Medical condition | Sjogren’s syndrome | Oral lesions | Location | Treatment |
|
1. ♀/44 | Negative | Diabetes | Primary | Erosive OLP | (i) Gingiva (ii) Inner surface of the cheeks | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) (iii) Dermocort (iv) Topical antifungal treatment |
|
2. ♀/52 | Negative | (i) Psoriasis (ii) Rheumatic psoriasis (iii) Vitamin D deficiency (iv) Allergy to Co, Cr, Ni | Secondary | Erosive OLP | (i) Inner surface of the cheeks (ii) Inner surface of the lips | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) (iii) Vitamin D supplementation |
|
3. ♂/65 | Not mentioned | (i) Gastric ulcer (ii) Anemia | Primary | Erosive OLP | (i) Dorsal side of the tongue (ii) Inner surface of the cheeks (iii) Inner surface of the lips | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) |
|
4. ♀/40 | (i) Negative (ii) Positive (iii) Rheumatoid factor | (i) Anemia (ii) Rheumatoid Arthritis | Secondary | Erosive OLP | (i) Inner surface of the cheeks (ii) Inner surface of the lips | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) |
|
5. ♀/51 | Anti-SSA + anti-SSB - | (i) Hypertension (ii) Hyperlipidemia (iii) Vitamin D deficiency (iv) Hysterectomy | Primary | Erosive OLP Vulvo-vaginal-gingival syndrome | (i) Gingiva (ii) Soft palate (iii) Esophageal mucosae (iv) Inner surface of the cheeks (v) Skin lesions (vi) Vulvar and vaginal lesions | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) (iii) Vitamin D supplementation (iv) General treatment with corticosteroids |
|
6. ♀/60 | Not mentioned | Vitamin D deficiency | Primary | Erosive OLP | Inner surface of the lips and cheeks | (i) Oral cavity conditioning (ii) Topical antifungal treatment (iii) Topical mouthwash (Solupred) (iv) Mouthwash (Chlorhexidine) (v) Vitamin D supplementation |
|
7. ♀/60 | Not mentioned | Vitamin D deficiency | Primary | Erythematosus OLL | Inner surface of the lips | (i) Oral cavity conditioning (ii) Topical antifungal treatment (iii) Topical mouthwash (Solupred) (iv) Mouthwash (Chlorhexidine) (v) Vitamin D supplementation (vi) Antibiotherapy (CLAMOXYL®). |
|
8. ♀/62 | Not mentioned | Diabetes | Primary | Erosive OLP | (i) Inner surface of the cheeks (ii) Skin lesions (iii) Vulvar and vaginal lesions | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) |
|
9. ♀/56 | Not mentioned | | Primary | Erosive OLP | Inner surface of the lips | (i) Oral cavity conditioning (ii) Topical mouthwash (Solupred) (iii) General treatment with corticosteroids |
|